Key result
High-sensitivity cardiac troponin I elevations at 12-16 hours post-CABG using a threshold of 8000 ng/L predicted repeat revascularization with an AUC of 0.92.
Why the study?
Current troponin cut-offs for post-operative workup after CABG rely on non-high-sensitive assays or are arbitrarily chosen, creating a need to identify optimal cut-offs and timing for hs-cTnI to guide clinical decision-making.
Does a specific high-sensitivity cardiac troponin I cut-off predict the need for repeat revascularization and adverse outcomes in patients after elective CABG?
Cohort (n=4,684)
No
Does a specific high-sensitivity cardiac troponin I cut-off predict the need for repeat revascularization and adverse outcomes in patients after elective CABG?
Answers are grounded in this paper and cite their sources.
Higher hs-cTnI cut-offs (>500x URL) than currently recommended are optimal for predicting the need for early repeat revascularization after elective CABG.
AIMS: Current troponin cut-offs suggested for the post-operative workup of patients following coronary artery bypass graft (CABG) surgery are based on studies using non-high-sensitive troponin assays or are arbitrarily chosen. We aimed to identify an optimal cut-off and timing for a proprietary high-sensitivity cardiac troponin I (hs-cTnI) assay to facilitate post-operative clinical decision-making. METHODS AND RESULTS: We performed a retrospective analysis of all patients undergoing elective isolated CABG at our centre between January 2013 and May 2019. Of 4684 consecutive patients, 161 patients (3.48%) underwent invasive coronary angiography after surgery, of whom 86 patients (53.4%) underwent repeat revascularization. We found an optimal cut-off value for peak hs-cTnI of >13 000 ng/L [>500× the upper reference limit (URL)] to be significantly associated with repeat revascularization within 48 h after surgery, which was internally validated through random repeated sampling with 1000 iterations. The same cut-off also predicted 30-day major adverse cardiovascular events and all-cause mortality after a median follow-up of 3.1 years, which was validated in an external cohort. A decision tree analysis of serial hs-cTnI measurements showed no added benefit of hs-cTnI measurements in patients with electrocardiographic or echocardiographic abnormalities or haemodynamic instability. Likewise, early post-operative hs-cTnI elevations had a low yield for clinical decision-making and only later elevations (at 12-16 h post-operatively) using a threshold of 8000 ng/L (307× URL) were significantly associated with repeat revascularization with an area under the curve of 0.92 (95% confidence interval 0.88-0.95). CONCLUSION: Our data suggest that for hs-cTnI, higher cut-offs than currently recommended should be used in the post-operative management of patients following CABG.
No takes yet. Share an insight, caveat, or question.
Omran et al. (2021) conducted a cohort in Post-operative coronary artery bypass grafting (CABG) (n=4,684). High-sensitivity cardiac troponin I (hs-cTnI) measurement was evaluated on Repeat revascularization within 48 h after surgery (AUC 0.92, 95% CI 0.88-0.95). High-sensitivity cardiac troponin I elevations at 12-16 hours post-CABG using a threshold of 8000 ng/L predicted repeat revascularization with an AUC of 0.92.
Synapse has enriched 10 related papers. Consider them for comparative context: